Clinical Trial: Spironolactone in Diabetic Nephropathy

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Spironolactone in Diabetic Nephropathy

Brief Summary: The aim of the study was to evaluate the renoprotective effect (i.e. albuminuria- and bloodpressure lowering effect) of spironolactone 25 mg o.d. in type 1 and type 2 diabetic patients with albuminuria despite recommended antihypertensive treatment.

Detailed Summary:
Sponsor: Steno Diabetes Center

Current Primary Outcome:

• Changes in albuminuria
• Changes in blood pressure

Original Primary Outcome: Same as current

Current Secondary Outcome: Changes in glomerular filtration rate

Original Secondary Outcome: Same as current

Information By: Steno Diabetes Center

Dates:
Date Received: April 21, 2006
Date Started: September 2003
Date Completion: July 2005
Last Updated: April 21, 2006
Last Verified: August 2005